CRIS Q2 2019 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-11.2% YoY

Gross Profit

$2M95.7% margin

Operating Income

-$6M-293.3% margin

Net Income

-$7M-344.5% margin

EPS (Diluted)

$-4.35

QoQ Revenue Growth

+18.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$631,000

Balance Sheet

Total Assets

$48M

Total Liabilities

$69M

Stockholders' Equity

-$20M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-11.2%
Gross Profit	$2M	$2M	-9.8%
Operating Income	-$6M	-$8M	+21.9%
Net Income	-$7M	-$9M	+16.7%

Revenue Segments

Contra Revenue

-$48,000